The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release - PubMed (original) (raw)
Review
The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release
Stephan Bour et al. Microbes Infect. 2003 Sep.
Free article
Abstract
HIV accessory genes are expressed throughout the viral life cycle and regulate wide-ranging aspects of virus replication including viral infectivity (Vif and Nef), viral gene expression (Vpr) and progeny virion production (Vpu). While in many cases the molecular basis of accessory protein function is not fully understood, a consensus is emerging that these viral products are generally devoid of enzymatic activity and instead act as multifunctional adapters, subverting normal cellular processes to serve the needs of the virus. This review focuses on presenting our current knowledge of the HIV-1-specific Vpu protein and its essential role in regulating viral particle release, viral load and expression of the CD4 receptor.
Similar articles
- Role of viral regulatory and accessory proteins in HIV-1 replication.
Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, Kashanchi F. Seelamgari A, et al. Front Biosci. 2004 Sep 1;9:2388-413. doi: 10.2741/1403. Front Biosci. 2004. PMID: 15353294 Review. - HIV accessory proteins: leading roles for the supporting cast.
Trono D. Trono D. Cell. 1995 Jul 28;82(2):189-92. doi: 10.1016/0092-8674(95)90306-2. Cell. 1995. PMID: 7628010 Review. No abstract available. - The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
Bour S, Schubert U, Peden K, Strebel K. Bour S, et al. J Virol. 1996 Feb;70(2):820-9. doi: 10.1128/JVI.70.2.820-829.1996. J Virol. 1996. PMID: 8551620 Free PMC article. - HIV accessory proteins: multifunctional components of a complex system.
Bour S, Strebel K. Bour S, et al. Adv Pharmacol. 2000;48:75-120. doi: 10.1016/s1054-3589(00)48004-x. Adv Pharmacol. 2000. PMID: 10987089 Review. No abstract available. - HIV accessory proteins as therapeutic targets.
Miller RH, Sarver N. Miller RH, et al. Nat Med. 1997 Apr;3(4):389-94. doi: 10.1038/nm0497-389. Nat Med. 1997. PMID: 9095171 Review. No abstract available.
Cited by
- Mechanisms of substrate processing during ER-associated protein degradation.
Christianson JC, Jarosch E, Sommer T. Christianson JC, et al. Nat Rev Mol Cell Biol. 2023 Nov;24(11):777-796. doi: 10.1038/s41580-023-00633-8. Epub 2023 Aug 1. Nat Rev Mol Cell Biol. 2023. PMID: 37528230 Review. - The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1).
Henke W, Waisner H, Arachchige SP, Kalamvoki M, Stephens E. Henke W, et al. Retrovirology. 2022 Nov 19;19(1):25. doi: 10.1186/s12977-022-00611-6. Retrovirology. 2022. PMID: 36403071 Free PMC article. - Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.
Khan N, Geiger JD. Khan N, et al. Viruses. 2021 Jul 27;13(8):1466. doi: 10.3390/v13081466. Viruses. 2021. PMID: 34452331 Free PMC article. Review. - HIV-2-Infected Macrophages Produce and Accumulate Poorly Infectious Viral Particles.
Gea-Mallorquí E, Zablocki-Thomas L, Maurin M, Jouve M, Rodrigues V, Ruffin N, Benaroch P. Gea-Mallorquí E, et al. Front Microbiol. 2020 Jul 10;11:1603. doi: 10.3389/fmicb.2020.01603. eCollection 2020. Front Microbiol. 2020. PMID: 32754142 Free PMC article. - Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
Colomer-Lluch M, Ruiz A, Moris A, Prado JG. Colomer-Lluch M, et al. Front Immunol. 2018 Dec 6;9:2876. doi: 10.3389/fimmu.2018.02876. eCollection 2018. Front Immunol. 2018. PMID: 30574147 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials